Lee, W.-C.; Wu, P.-J.; Fang, H.-Y.; Fang, Y.-N.; Chen, H.-C.; Tong, M.-S.; Sung, P.-H.; Lee, C.-H.; Chung, W.-J.
Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure. J. Clin. Med. 2022, 11, 3997.
https://doi.org/10.3390/jcm11143997
AMA Style
Lee W-C, Wu P-J, Fang H-Y, Fang Y-N, Chen H-C, Tong M-S, Sung P-H, Lee C-H, Chung W-J.
Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure. Journal of Clinical Medicine. 2022; 11(14):3997.
https://doi.org/10.3390/jcm11143997
Chicago/Turabian Style
Lee, Wei-Chieh, Po-Jui Wu, Hsiu-Yu Fang, Yen-Nan Fang, Huang-Chung Chen, Meng-Shen Tong, Pei-Hsun Sung, Chieh-Ho Lee, and Wen-Jung Chung.
2022. "Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure" Journal of Clinical Medicine 11, no. 14: 3997.
https://doi.org/10.3390/jcm11143997
APA Style
Lee, W. -C., Wu, P. -J., Fang, H. -Y., Fang, Y. -N., Chen, H. -C., Tong, M. -S., Sung, P. -H., Lee, C. -H., & Chung, W. -J.
(2022). Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure. Journal of Clinical Medicine, 11(14), 3997.
https://doi.org/10.3390/jcm11143997